IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancer by Stabile, L.P, Egloff, A.M, Gibson, M.K, Gooding, W.E, Ohr, J, Zhou, P, Rothenberger, N.J, Wang, L, Geiger, J.L, Flaherty, J.T, Grandis, J.R, Bauman, J.E

Get full text

The Impact of Perineural Invasion in Patients with Esophageal Adenocarcinoma Treated with Esophagectomy by Mehta, K.S, Bianco, V, Hamilton, A, Gooding, W.E, Luketich, J.D, Pennathur, A

Get full text

Integrated Genomic Analysis of Esophageal Adenocarcinoma Identifies DNA Copy Number Changes and Related Gene Expression Alterations That are Associated With Survival by Godfrey, T.E, Bandla, S, Zhou, Z, Pennathur, A, Litle, V.R, Beer, D.G, Chang, A.C, Lin, L, Gooding, W.E, Bass, A, Dulak, A, Almudevar, A, Luketich, J.D

Get full text

Phase I study of gemcitabine given weekly as a short infusion for non-small cell lung cancer: results and possible immune system-related mechanisms by Levitt, M.L, Kassem, B, Gooding, W.E, Miketic, L.M, Landreneau, R.J, Ferson, P.F, Keenan, R, Yousem, S.A, Lindberg, C.A, Trenn, M.R, Ponas, R.S, Tarasoff, P, Sabatine, J.M, Friberg, D, Whiteside, T.L

Get full text

Subscriber data management in personal communications services networks by Garg, V.K., Sneed, E.L., Gooding, W.E.

Get full text